Author:
Ye Linlin,Liu Yao,Xiang Xuan,Wang Zihao,Peng Wenbei,Wei Xiaoshan,Zhang Siyu,Xue Qianqian,Zhou Qiong
Funder
National Natural Science Foundation of China
Reference45 articles.
1. Cancer statistics;Siegel;CA Cancer J Clin,2019
2. Neoadjuvant PD-1/PD-L1 inhibitors for resectable head and neck cancer: a systematic review and meta-analysis;Masarwy;JAMA Otolaryngol Head Neck Surg,2021
3. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship;Molina;Mayo Clin. Proc.,2008
4. Immunotherapy in non-small cell lung cancer treatment: current status and the role of imaging;Carter;J. Thorac. Imag.,2017
5. Neoadjuvant immunotherapy for non-small cell lung cancer: right drugs, right patient, right time?;Ahern;J Immunother Cancer,2021